Mills-Peninsula Medical Center — Burlingame, California

Public research footprint of Mills-Peninsula Medical Center, compiled from the ClinicalTrials.gov public registry.

136

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Neuroendocrine Neoplasm · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIB Lung Cancer AJCC v8 · Recurrent Ovarian Carcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mills-Peninsula Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.